Cognitive Functioning in Adults With Somatic Diseases and General Population From a Biopsychosocial Perspective
Launched by BARTOSZ M. RADTKE · Apr 10, 2024
Trial Information
Current as of July 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how cognitive functions, such as memory and language skills, differ among adults, including those with a condition called aphasia, which affects their ability to communicate. The researchers want to understand how these cognitive profiles vary by age and gender within a group of at least 600 adults aged 18 and older. They will compare people from the general population to those with recognized aphasic syndromes, as well as seniors over 60 years old, to see if there are specific patterns in how people learn and remember things.
To participate, individuals must meet certain criteria. For example, if you are part of the general population, you should be between 18 and 60 years old. Those with aphasia must be over 18, and seniors must be over 60. During the study, qualified professionals will assess your memory, learning, and language skills, while also gathering information about your health history. This research aims to provide valuable insights that could help improve support and treatment for individuals with cognitive challenges.
Gender
ALL
Eligibility criteria
- Inclusion criteria for general population/control group:
- • age from 18 to 60 y.o.
- • Inclusion criteria for neurologically recognized aphasic syndromes
- • age above 18 y.o.
- • neurologically recognized aphasic syndromes
- Inclusion criteria for seniors:
- • age above 60 y.o.
- Exclusion criteria for general population/control group:
- • age less then 18 y.o.
- • neurologically recognized aphasic syndromes
- • Exclusion criteria for neurologically recognized aphasic syndromes
- • age less then 18 y.o.
- • no neurologically recognized aphasic syndromes
- • Exclusion criteria for seniors
- • age less then 60 y.o.
- • diseases of the nervous system, such as: stroke, craniocerebral trauma, neuroinfections, neurodegenerative diseases
- • mental disorders such as depression, psychotic disorders, anxiety disorders, addictions
About Bartosz M. Radtke
Bartosz M. Radtke is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through rigorous scientific inquiry. With a strong focus on innovative therapeutic approaches, the organization collaborates with leading research institutions and healthcare professionals to design and implement clinical trials that adhere to the highest ethical and regulatory standards. Leveraging extensive expertise in trial management and a deep understanding of patient needs, Bartosz M. Radtke aims to facilitate the development of safe and effective treatments across various therapeutic areas, ultimately contributing to the enhancement of healthcare practices and patient quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gdansk, Pomerania, Poland
Patients applied
Trial Officials
Urszula Sajewicz-Radtke, Ph.D.
Study Director
Laboratory of Psychological and Educational Tests
Bartosz M Radtke, Ph.D.
Principal Investigator
Laboratory of Psychological and Educational Tests
Ariadna Łada-Maśko, Ph.D.
Principal Investigator
Laboratory of Psychological and Educational Tests
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported